These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 27100731)

  • 1. Validation of a contemporary prostate cancer grading system using prostate cancer death as outcome.
    Berney DM; Beltran L; Fisher G; North BV; Greenberg D; Møller H; Soosay G; Scardino P; Cuzick J
    Br J Cancer; 2016 May; 114(10):1078-83. PubMed ID: 27100731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The percentage of high-grade prostatic adenocarcinoma in prostate biopsies significantly improves on Grade Groups in the prediction of prostate cancer death.
    Berney DM; Beltran L; Sandu H; Soosay G; Møller H; Scardino P; Murphy J; Ahmad A; Cuzick J;
    Histopathology; 2019 Oct; 75(4):589-597. PubMed ID: 31032963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of association of prostate carcinoma nuclear grading with prostate specific antigen recurrence after radical prostatectomy.
    Zhou M; Hayasaka S; Taylor JM; Shah R; Proverbs-Singh T; Manley S; Rubin MA
    J Urol; 2001 Dec; 166(6):2193-7. PubMed ID: 11696734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score.
    Epstein JI; Zelefsky MJ; Sjoberg DD; Nelson JB; Egevad L; Magi-Galluzzi C; Vickers AJ; Parwani AV; Reuter VE; Fine SW; Eastham JA; Wiklund P; Han M; Reddy CA; Ciezki JP; Nyberg T; Klein EA
    Eur Urol; 2016 Mar; 69(3):428-35. PubMed ID: 26166626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gleason grade grouping of prostate cancer is of prognostic value in Asian men.
    Yeong J; Sultana R; Teo J; Huang HH; Yuen J; Tan PH; Khor LY
    J Clin Pathol; 2017 Sep; 70(9):745-753. PubMed ID: 28289065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New Prostate Cancer Grading System Predicts Long-term Survival Following Surgery for Gleason Score 8-10 Prostate Cancer.
    Ham WS; Chalfin HJ; Feng Z; Trock BJ; Epstein JI; Cheung C; Humphreys E; Partin AW; Han M
    Eur Urol; 2017 Jun; 71(6):907-912. PubMed ID: 27876305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should we replace the Gleason score with the amount of high-grade prostate cancer?
    Vis AN; Roemeling S; Kranse R; Schröder FH; van der Kwast TH
    Eur Urol; 2007 Apr; 51(4):931-9. PubMed ID: 16935413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Significance of Percentage and Architectural Types of Contemporary Gleason Pattern 4 Prostate Cancer in Radical Prostatectomy.
    Choy B; Pearce SM; Anderson BB; Shalhav AL; Zagaja G; Eggener SE; Paner GP
    Am J Surg Pathol; 2016 Oct; 40(10):1400-6. PubMed ID: 27379821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gleason score 5 + 3 = 8 (grade group 4) prostate cancer-a rare occurrence with contemporary grading.
    Kryvenko ON; Williamson SR; Schwartz LE; Epstein JI
    Hum Pathol; 2020 Mar; 97():40-51. PubMed ID: 31923450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of Gleason score 3 + 4 = 7 prostate cancer with minimal amounts (<6%) vs ≥6% of Gleason pattern 4 tissue in needle biopsy specimens.
    Kır G; Seneldir H; Gumus E
    Ann Diagn Pathol; 2016 Feb; 20():48-51. PubMed ID: 26750655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics and outcome of prostate cancer patients with overall biopsy Gleason score 3 + 4 = 7 and highest Gleason score 3 + 4 = 7 or > 3 + 4 = 7.
    Verhoef EI; Kweldam CF; Kümmerlin IP; Nieboer D; Bangma CH; Incrocci L; van der Kwast TH; Roobol MJ; van Leenders GJ
    Histopathology; 2018 Apr; 72(5):760-765. PubMed ID: 29094386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate-specific antigen vs prostate-specific antigen density as a predictor of upgrading in men diagnosed with Gleason 6 prostate cancer by contemporary multicore prostate biopsy.
    Oh JJ; Hong SK; Lee JK; Lee BK; Lee S; Kwon OS; Byun SS; Lee SE
    BJU Int; 2012 Dec; 110(11 Pt B):E494-9. PubMed ID: 22540236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate cancer outcomes of men with biopsy Gleason score 6 and 7 without cribriform or intraductal carcinoma.
    Kweldam CF; Kümmerlin IP; Nieboer D; Verhoef EI; Steyerberg EW; Incrocci L; Bangma CH; van der Kwast TH; Roobol MJ; van Leenders GJ
    Eur J Cancer; 2016 Oct; 66():26-33. PubMed ID: 27522247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Utility of Quantitative Gleason Grading in Prostate Biopsies and Prostatectomy Specimens.
    Sauter G; Steurer S; Clauditz TS; Krech T; Wittmer C; Lutz F; Lennartz M; Janssen T; Hakimi N; Simon R; von Petersdorff-Campen M; Jacobsen F; von Loga K; Wilczak W; Minner S; Tsourlakis MC; Chirico V; Haese A; Heinzer H; Beyer B; Graefen M; Michl U; Salomon G; Steuber T; Budäus LH; Hekeler E; Malsy-Mink J; Kutzera S; Fraune C; Göbel C; Huland H; Schlomm T
    Eur Urol; 2016 Apr; 69(4):592-598. PubMed ID: 26542947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative Prostate-specific Antigen Isoform p2PSA and Its Derivatives, %p2PSA and Prostate Health Index, Predict Pathologic Outcomes in Patients Undergoing Radical Prostatectomy for Prostate Cancer: Results from a Multicentric European Prospective Study.
    Fossati N; Buffi NM; Haese A; Stephan C; Larcher A; McNicholas T; de la Taille A; Freschi M; Lughezzani G; Abrate A; Bini V; Palou Redorta J; Graefen M; Guazzoni G; Lazzeri M
    Eur Urol; 2015 Jul; 68(1):132-8. PubMed ID: 25139197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of very low prostate-specific antigen levels with increased cancer-specific death in men with high-grade prostate cancer.
    Mahal BA; Aizer AA; Efstathiou JA; Nguyen PL
    Cancer; 2016 Jan; 122(1):78-83. PubMed ID: 26371600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of Preoperative and Radical Prostatectomy Gleason Score: Examining the Predictors of Upgrade and Downgrade Results.
    Pourmand G; Gooran S; Hossieni SR; Guitynavard F; Safavi M; Sharifi A; Mokhtari E
    Acta Med Iran; 2017 Apr; 55(4):249-253. PubMed ID: 28532136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PI-RADS version 2 for prediction of pathological downgrading after radical prostatectomy: a preliminary study in patients with biopsy-proven Gleason Score 7 (3+4) prostate cancer.
    Woo S; Kim SY; Lee J; Kim SH; Cho JY
    Eur Radiol; 2016 Oct; 26(10):3580-7. PubMed ID: 26847042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of primary Gleason pattern in Japanese men with Gleason score 7 prostate cancer treated with radical prostatectomy.
    Miyake H; Muramaki M; Furukawa J; Tanaka H; Inoue TA; Fujisawa M
    Urol Oncol; 2013 Nov; 31(8):1511-6. PubMed ID: 22658882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of percentage Gleason grade 5 prostatic adenocarcinoma in needle biopsies from patients treated by radical prostatectomy.
    Yaxley W; Delahunt B; Yaxley J; Thunders MC; Kenwright DN; Egevad L; Samaratunga H
    Pathology; 2022 Oct; 54(6):694-699. PubMed ID: 35613972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.